Credit Suisse Raises Price Target & Cuts Estimates on Human Genome Sciences (HGSI),
Tweet Send to a Friend
Credit Suisse is reiterating their Outperform rating and is raising their price target to $34 from $32 on shares of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
